BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12644028)

  • 1. Factors that influence therapeutic outcomes in symptomatic gastroesophageal reflux disease.
    Quigley EM
    Am J Gastroenterol; 2003 Mar; 98(3 Suppl):S24-30. PubMed ID: 12644028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower esophageal sphincter injections for the treatment of gastroesophageal reflux disease.
    Watson TJ; Peters JH
    Thorac Surg Clin; 2005 Aug; 15(3):405-15. PubMed ID: 16104131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastroesophageal reflux disease: presentation and assessment of a common, challenging disorder.
    Soll AH; Fass R
    Clin Cornerstone; 2003; 5(4):2-14; discussion 14-7. PubMed ID: 15101491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastroesophageal reflux disease: clinical manifestations.
    Williams JL
    Gastroenterol Nurs; 2003; 26(5):195-200. PubMed ID: 14603078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AGA Clinical Practice Update on Functional Heartburn: Expert Review.
    Fass R; Zerbib F; Gyawali CP
    Gastroenterology; 2020 Jun; 158(8):2286-2293. PubMed ID: 32017911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastroesophageal reflux: management guidance for the pediatrician.
    Lightdale JR; Gremse DA;
    Pediatrics; 2013 May; 131(5):e1684-95. PubMed ID: 23629618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradigm shift in the management of gastroesophageal reflux disease.
    Richards WO; Houston HL; Torquati A; Khaitan L; Holzman MD; Sharp KW
    Ann Surg; 2003 May; 237(5):638-47; discussion 648-9. PubMed ID: 12724630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both?
    Tack J; Koek G; Demedts I; Sifrim D; Janssens J
    Am J Gastroenterol; 2004 Jun; 99(6):981-8. PubMed ID: 15180713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Gastroesophageal Reflux Disease in Asian Countries: Results of a Questionnaire Survey.
    Hojo M; Nagahara A; Hahm KB; Iwakiri R; Watanabe T; Rani AA; Zhu Q; Chan FKL; Sollano JD; Kamiya T; Yamaguchi S; Motoya S; Fock KM; Fukudo S; Kachintorn U; Suzuki H; Murakami K;
    Digestion; 2020; 101(1):66-79. PubMed ID: 31801133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastroesophageal reflux disease.
    Howden CW; Chey WD
    J Fam Pract; 2003 Mar; 52(3):240-7. PubMed ID: 12620183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: approaches to endoscopic-negative reflux disease: part of the GERD spectrum or a unique acid-related disorder?
    Tack J; Fass R
    Aliment Pharmacol Ther; 2004 Feb; 19 Suppl 1():28-34. PubMed ID: 14725576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of esophageal function/pH in endoscopic therapy for gastroesophageal reflux disease.
    Johnson DA
    Gastrointest Endosc Clin N Am; 2005 Apr; 15(2):333-45. PubMed ID: 15722245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of antireflux surgery in patients with normal preoperative 24-hour pH test results.
    Khajanchee YS; Hong D; Hansen PD; Swanström LL
    Am J Surg; 2004 May; 187(5):599-603. PubMed ID: 15135673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A primary care approach to pediatric gastroesophageal reflux.
    Sunku B; Marino RV; Sockolow R
    J Am Osteopath Assoc; 2000 Dec; 100(12 Suppl Pt 2):S11-5. PubMed ID: 11213657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
    Endzinas Z; Mickevicius A; Kiudelis M
    Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
    Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
    Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the diagnosis and management of gastroesophageal reflux disease.
    Katzka DA; Kahrilas PJ
    BMJ; 2020 Nov; 371():m3786. PubMed ID: 33229333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of symptoms in gastroesophageal reflux disease: nonerosive reflux disease, symptomatic, and silent erosive reflux disease.
    Choi JY; Jung HK; Song EM; Shim KN; Jung SA
    Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):764-71. PubMed ID: 23459104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonerosive reflux disease.
    Long JD; Orlando RC
    Minerva Gastroenterol Dietol; 2007 Jun; 53(2):127-41. PubMed ID: 17557041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.